Cancer Research Institute of Contra Costa Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
1997
NCT00007891
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1997

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 5